3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Myelodysplastic Syndromes
16
Leukemia, Lymphocytic, Chronic, B-Cell
13
Lymphoma, Non-Hodgkin
10
Lymphoma
9
Multiple Myeloma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Leukemia
8
Recurrence
6
Hodgkin Disease
6
Myeloproliferative Disorders
5
Lymphoma, Mantle-Cell
5
Lymphoma, B-Cell
5
Leukemia, Biphenotypic, Acute
5
Neoplasms
4
Neoplasm, Residual
4
Melanoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Leukemia, Myelomonocytic, Juvenile
4
Leukemia, Lymphoid
4
Immunoproliferative Disorders
4
Immune System Diseases
4
Burkitt Lymphoma
4
Precancerous Conditions
3
Lymphoproliferative Disorders
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphatic Diseases
3
Leukemia, Myelomonocytic, Chronic
3
Interventions
durvalumab
7
Bevacizumab
6
tremelimumab
3
Nivolumab
3
lenvatinib
2
fludarabine
2
Cyclophosphamide
2
zimberelimab
1
toripalimab
1
ropidoxuridine
1
relatlimab
1
pembrolizumab
1
fludarabine phosphate
1
atezolizumab
1
X-Rays
1
Technetium Tc 99m Aggregated Albumin
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radionuclide Imaging
1
Platinum
1
Photons
1
Paclitaxel
1
Observation
1
Long-Term Potentiation
1
Lidocaine
1
Immunotherapy
1
Immunoglobulin G
1
IMC-001
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Liver Neoplasms
×
fludarabine phosphate
×
Clear all
NCT02932956
2025-09-19
GAP
Baylor College of Medicine
Phase 1
Active not recruiting
10 enrolled